Go Pro
→ 'Second Wave” Hitting Iran Soon? Wall Street Issues Warning (From TradeSmith) (Ad)tc pixel Free ENTA Stock Alerts

Enanta Pharmaceuticals (ENTA) Short Interest Ratio & Short Volume

Enanta Pharmaceuticals logo
$13.46 +0.51 (+3.94%)
As of 12:08 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Enanta Pharmaceuticals Short Interest Overview

As of July 15, 2026, Enanta Pharmaceuticals (ENTA) had a short interest of 2.44 million shares sold short, representing 9.48% of the public float. This marks a -5.51% decrease in short interest since the prior report. The short interest ratio (days to cover) is 12.8, meaning it would take 12.8 days of the average trading volume of 194,771 shares to cover all short positions.

Current Short Interest
2,441,185 shares
Previous Short Interest
2,583,579 shares
Change Vs. Previous Month
-5.51%
Dollar Volume Sold Short
$32.30 million
Short Interest Ratio
12.8 Days to Cover
Last Record Date
July 15, 2026
Outstanding Shares
29,080,000 shares
Short Percent of Float
9.48%
Today's Trading Volume
74,492 shares
Average Trading Volume
194,771 shares
Today's Volume Vs. Average
38%
Short Selling Enanta Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Enanta Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ENTA Short Interest Over Time

ENTA Days to Cover Over Time

ENTA Percentage of Float Shorted Over Time

Enanta Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/20262,441,185 shares $32.30 million -5.5%9.5%12.77 $13.23
6/30/20262,583,579 shares $37.67 million +6.4%10.0%8.09 $14.58
6/15/20262,427,371 shares $27.77 million +6.7%9.4%12.8 $11.44
5/29/20262,274,248 shares $29.93 million +3.3%8.8%10.96 $13.16
5/15/20262,202,731 shares $29.54 million +2.2%8.6%9.37 $13.41
4/30/20262,155,192 shares $29.94 million +2.6%8.4%18.82 $13.89
4/15/20262,101,431 shares $30.58 million -1.5%8.2%17.29 $14.55
3/31/20262,133,058 shares $26.94 million -1.4%8.3%15.54 $12.63
3/13/20262,163,844 shares $27.48 million -1.1%8.4%11.24 $12.70
2/27/20262,187,043 shares $31.27 million -3.9%8.5%12.1 $14.30
2/13/20262,275,475 shares $31.52 million +0.7%8.8%11.63 $13.85
1/30/20262,260,780 shares $29.16 million +0.3%8.8%10.23 $12.90
1/15/20262,255,154 shares $30.11 million +8.2%9.1%8.47 $13.35
12/31/20252,083,389 shares $32.86 million -8.8%8.4%4.45 $15.77
12/15/20252,284,705 shares $33.97 million -7.9%9.2%7.72 $14.87
11/28/20252,480,681 shares $35.04 million -11.5%10.0%7.6 $14.13
11/14/20252,803,161 shares $33.81 million +2.5%15.2%9.41 $12.06
10/31/20252,734,788 shares $29.97 million -2.8%14.9%5.22 $10.96
10/15/20252,810,000 shares $32.82 million -16.1%15.3%4.4 $11.68
9/30/20253,350,000 shares $40.10 million +17.5%N/A5.7 $11.97
9/15/20252,850,000 shares $21.26 million +0.7%14.4%15.8 $7.46
8/31/20252,830,000 shares $23.77 million -1.7%14.3%16.3 $8.40
8/15/20252,880,000 shares $23.04 million +5.5%14.5%16.9 $8.00
7/31/20252,730,000 shares $20.69 million +11.0%13.8%17 $7.58
7/15/20252,460,000 shares $16.21 million +1.7%12.4%15.2 $6.59
6/30/20252,420,000 shares $18.30 million -3.2%12.2%13.3 $7.56
6/15/20252,500,000 shares $18.75 million -8.1%12.6%13.3 $7.50
5/31/20252,720,000 shares $16.24 million -4.6%13.7%13.9 $5.97
5/15/20252,850,000 shares $15.30 million -3.7%14.4%12.7 $5.37
4/30/20252,960,000 shares $18.03 million +5.7%14.9%9.1 $6.09
4/15/20252,800,000 shares $14.42 million +4.9%14.1%8.1 $5.15
3/31/20252,670,000 shares $14.74 million +1.5%13.5%6.3 $5.52
3/15/20252,630,000 shares $17.49 million +1.2%13.3%5.2 $6.65
2/28/20252,600,000 shares $20.23 million -27.2%13.1%4.6 $7.78
2/15/20253,570,000 shares $25.49 million +6.3%18.0%6.2 $7.14
1/31/20253,360,000 shares $17.17 million +4.0%16.9%6.9 $5.11
1/15/20253,230,000 shares $15.57 million -3.6%16.4%7.3 $4.82
12/31/20243,350,000 shares $19.26 million -0.6%17.0%8.8 $5.75
12/15/20243,370,000 shares $20.32 million +4.3%17.1%12.2 $6.03
11/30/20243,230,000 shares $27.78 million -4.4%16.4%15.2 $8.60
The Market Hasn't Fully Caught This Yet (Ad)

Surface samples on this project have returned grades up to 73 g/t gold and 21% copper, right next to a producer valued at roughly $4.5 billion. A second drill rig is now turning on the property, adding fresh data to an already intriguing early-stage story. Nothing underground is confirmed yet, but the setup mirrors how some of the biggest mining moves have started.tc pixel

See the early clues before the broader market catches on
11/15/20243,380,000 shares $32.21 million -1.7%17.2%20 $9.53
10/31/20243,440,000 shares $38.68 million +0.3%17.5%22 $11.25
10/15/20243,430,000 shares $40.03 million +14.7%17.4%20.7 $11.67
9/30/20242,990,000 shares $30.98 million +2.4%15.2%16.5 $10.36
9/15/20242,920,000 shares $36.30 million +0.3%14.8%16.9 $12.43
8/31/20242,910,000 shares $37.48 million -1.7%14.8%16.7 $12.88
8/15/20242,960,000 shares $36.29 million +5.7%15.0%16 $12.26
7/31/20242,800,000 shares $41.33 million -3.8%14.2%15.7 $14.76
7/15/20242,910,000 shares $48.13 million -3.3%14.8%16.6 $16.54
6/30/20243,010,000 shares $39.04 million +9.1%15.3%18.3 $12.97
6/15/20242,760,000 shares $35.44 million No Change14.0%15.3 $12.84
5/31/20242,760,000 shares $34.42 million -1.4%14.0%14.7 $12.47
5/15/20242,800,000 shares $37.35 million +0.7%14.2%14.5 $13.34
4/30/20242,780,000 shares $38.20 million +1.5%14.2%12.5 $13.74
4/15/20242,740,000 shares $44.25 million No Change13.9%12 $16.15
3/31/20242,740,000 shares $47.84 million +13.7%13.9%10.4 $17.46
3/15/20242,410,000 shares $34.25 million +15.3%12.3%9.2 $14.21
2/29/20242,090,000 shares $30.03 million -5.4%10.6%8 $14.37
2/15/20242,210,000 shares $29.30 million +20.1%11.2%8.2 $13.26
1/31/20241,840,000 shares $22.36 million +15.7%9.3%6.5 $12.15
1/15/20241,590,000 shares $17.82 million +2.6%8.1%5.4 $11.21
12/31/20231,550,000 shares $14.59 million -13.9%7.9%5.4 $9.41
12/15/20231,800,000 shares $16.81 million +22.5%9.2%6.4 $9.34
11/30/20231,470,000 shares $13.73 million -2.7%7.5%3.4 $9.34
11/15/20231,510,000 shares $13.21 million +12.7%7.7%3.3 $8.75
10/31/20231,340,000 shares $12.09 million +3.9%6.9%3.1 $9.02
10/15/20231,290,000 shares $12.42 million +8.4%6.6%3 $9.63
9/30/20231,190,000 shares $13.29 million -42.0%6.8%2.9 $11.17
9/15/20232,050,000 shares $26.10 million +22.0%10.5%5.2 $12.73
8/31/20231,680,000 shares $24.95 million +16.7%8.6%6 $14.85
8/15/20231,440,000 shares $22.82 million No Change7.4%6.4 $15.85
7/31/20231,440,000 shares $27.32 million +5.9%7.4%6 $18.97
7/15/20231,360,000 shares $26.14 million +14.3%7.0%5.9 $19.22
6/30/20231,190,000 shares $25.47 million +47.3%6.2%5.3 $21.40
6/15/2023808,100 shares $19.54 million +2.3%4.2%3.7 $24.18
5/31/2023789,600 shares $18.54 million +18.2%4.1%3.9 $23.48
5/15/2023667,800 shares $17.28 million -6.4%3.5%3.4 $25.87
4/30/2023713,500 shares $25.36 million -2.4%3.7%3.8 $35.55
4/15/2023730,800 shares $26.70 million +4.8%3.8%4.2 $36.53
3/31/2023697,100 shares $28.19 million -22.6%3.6%3.9 $40.44
3/15/2023900,100 shares $40.06 million +20.0%4.7%5.3 $44.51
2/28/2023750,300 shares $36.39 million -8.4%3.9%4.8 $48.50
2/15/2023819,500 shares $41.12 million -3.8%4.3%5.1 $50.18
1/31/2023851,400 shares $45.45 million +0.4%4.4%5.5 $53.38
1/15/2023847,700 shares $43.62 million -1.6%4.4%5 $51.46
12/30/2022861,500 shares $40.08 million -6.0%4.5%5 $46.52
12/15/2022916,400 shares $40.17 million -11.9%4.8%5.1 $43.84
11/30/20221,040,000 shares $45.54 million +4.2%5.4%5.4 $43.79
11/15/2022998,400 shares $47.14 million -4.0%5.2%4.9 $47.22
10/31/20221,040,000 shares $46.91 million -17.5%5.4%5.1 $45.11
Jim Rogers and Robert Kiyosaki just made the same call (Ad)

Jim Rogers co-founded the Quantum Fund with George Soros and returned 4200% over 10 years, compared to the S&P 500's 47% return in the same period. He's now saying gold and silver are going to the moon. Robert Kiyosaki agrees, revealing he bought more gold and silver during the recent retracement, even as silver trades 52% below its highs. Two of the most successful investors of the last 50 years are making the same move.tc pixel

See the stock designed to amplify silver's gains 3X to 5X
10/15/20221,260,000 shares $59.16 million -2.3%6.5%6 $46.95
9/30/20221,290,000 shares $66.91 million -5.2%6.7%6.4 $51.87
9/15/20221,360,000 shares $78.77 million -8.1%7.0%6.1 $57.92
8/31/20221,480,000 shares $90.10 million -3.3%7.7%6.1 $60.88
8/15/20221,530,000 shares $107.80 million -8.9%7.9%6.1 $70.46
7/31/20221,680,000 shares $92.65 million +3.1%8.7%5.8 $55.15
7/15/20221,630,000 shares $83.64 million -1.8%8.4%5.9 $51.31
6/30/20221,660,000 shares $78.47 million +5.7%8.6%5.8 $47.27
6/15/20221,570,000 shares $62.80 million +6.1%10.7%5.8 $40.00
5/31/20221,480,000 shares $59.10 million +10.5%7.7%6.2 $39.93
5/15/20221,340,000 shares $66.84 million +10.7%6.9%5.5 $49.88
4/30/20221,210,000 shares $77.92 million +9.0%6.3%5.6 $64.40
4/15/20221,110,000 shares $82.42 million -5.9%5.8%5.2 $74.25
3/31/20221,180,000 shares $83.99 million +9.3%6.1%5.4 $71.18
3/15/20221,080,000 shares $70.87 million +21.9%5.6%5.1 $65.62
2/28/2022886,300 shares $62.41 million +13.7%4.6%4 $70.42
2/15/2022779,800 shares $48.51 million -16.5%4.1%3.5 $62.21
1/31/2022933,700 shares $55.48 million +28.6%5.2%4.3 $59.42
1/15/2022726,100 shares $43.57 million +4.0%N/A0 $60.00
12/31/2021697,900 shares $52.19 million -2.4%3.9%3.5 $74.78
12/15/2021715,300 shares $52.22 million +5.4%4.0%3.6 $73.00
11/30/2021678,900 shares $59.93 million -0.3%3.8%3.7 $88.28
11/15/2021681,000 shares $61.21 million -36.9%3.8%4 $89.88
10/29/20211,080,000 shares $92.72 million -32.1%6.1%6.7 $85.85
10/15/20211,590,000 shares $113.64 million -9.7%8.9%10.8 $71.47
9/30/20211,760,000 shares $99.99 million -2.8%9.9%11.8 $56.81
9/15/20211,810,000 shares $106.16 million -7.2%10.1%11.7 $58.65
8/31/20211,950,000 shares $111.54 million -8.9%10.9%12 $57.20
8/13/20212,140,000 shares $100.90 million +4.9%12.0%13.8 $47.15

ENTA Short Interest - Frequently Asked Questions

Short interest is the volume of Enanta Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 2,441,185 shares of ENTA short. 9.48% of Enanta Pharmaceuticals' shares are currently sold short. Learn More on Enanta Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENTA shares currently have a short interest ratio of 12.8. Learn More on Enanta Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.48% of Enanta Pharmaceuticals' floating shares are currently sold short.

Enanta Pharmaceuticals saw a decrease in short interest in July. As of July 15th, there was short interest totaling 2,441,185 shares, a decrease of 5.5% from the previous total of 2,583,579 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

9.48% of Enanta Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to Enanta Pharmaceuticals: Xencor, Inc. (15.41%), Anbio Biotechnology (0.02%), MoonLake Immunotherapeutics (9.60%), Phibro Animal Health Corporation (6.02%), Xeris Biopharma Holdings, Inc. (6.10%), ArriVent BioPharma, Inc. (18.00%), Harrow, Inc. (21.06%), Aktis Oncology (7.24%), Ardelyx, Inc. (11.22%), Oric Pharmaceuticals, Inc. (22.59%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.09 billion), Invesco QQQ ($48.11 billion), iShares Russell 2000 ETF ($23.61 billion), Sandisk Corporation ($12.69 billion), Nebius Group N.V. ($12.18 billion), Western Digital Corporation ($11.95 billion), SPDR S&P Biotech ETF ($11.73 billion), Quhuo Limited Sponsored ADR ($9.74 billion), VanEck Semiconductor ETF ($9.57 billion), and Financial Select Sector SPDR Fund ($8.43 billion). View all of the most shorted stocks.

Short selling ENTA is an investing strategy that aims to generate trading profit from Enanta Pharmaceuticals as its price is falling. ENTA shares are trading up $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Enanta Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENTA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENTA, twice per month. The most recent reporting period available is July, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ENTA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:ENTA) was last updated on 7/24/2026 by MarketBeat.com Staff.
From Our Partners
"Second Wave” Hitting Iran Soon? Wall Street Issues Warning
Analysts at Goldman Sachs and Morgan Stanley are warning that a quiet domestic threat - unrelated to overseas ...
TradeSmith | Sponsoredtc pixel
1 Stock to Own by July 31st
A scheduled announcement on July 31st could reshuffle the stock market's winners and losers - and one lesser-k...
Chaikin Analytics | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
This AI fund sends investors payouts every Thursday
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
He bet half his $9 billion on ONE stock
One of the most successful fund managers of the past 50 years put more than $4.5 billion - over half his fund ...
Stansberry Research | Sponsoredtc pixel
The dollar reset no one told you about
Porter Stansberry says a dollar reset is underway - one that has happened only once before in America's 250-ye...
Porter & Company | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Simple Options Trading For Beginners' book at no cost - normally $29.97. It ou...
Profits Run | Sponsoredtc pixel